Many Delaware beachgoers feel the sting of a blooming jellyfish population
Beach patrol captains reported a dramatic increase in jellyfish activity and stings in July, the most they've seen in recent memory. Lewes Beach reported a fourfold increase in stings compared to 2024.
Lion's manes, which can have 100-foot (30-meter) tentacles, sea nettles and moon jellyfish are some varieties that frequent Delaware's summertime waters.
Jellyfish blooms have become common from Maine to Florida in recent years. Warming waters can create ideal conditions for jellyfish growth.
Normally, Delaware's five state parks may report a handful of summer jellyfish stings, said Bailey Noel, a beach patrol captain. But Fenwick Island State Park recently reported 92 stings on a single July day. Three lifeguards were taken to urgent care after swimming in jellyfish-infested waters, Noel said.
The jellyfish at Delaware's Towers Beach surprised Philadelphia resident Christina Jones, whose two daughters refused to wade back into the water after being stung, she said.
'The jellyfish are pretty bad,' Jones said. 'And not only are they a lot in number, but they're pretty big.'
Delaware State Beach Patrol started tracking jellyfish stings this year due to the rise in cases, said Noel. Most patrol teams do not track the data.
Lewes Beach Patrol treated 295 stings in 2024, the first year the data was collected, but reported over 1,200 cases so far in 2025, said Capt. Strohm Edwards. Lifeguards started carrying vinegar solutions, which can neutralize the venom agents, to help ease pain, he said.
But vinegar solutions may cause microscopic venom-coated barbs known as nematocysts to discharge, according to some research. Those experts recommend a baking soda slurry.
While venomous, stings from Delaware's lion's manes and sea nettles typically only cause minor irritation and pain, said Edwards. In cases of severe allergic reactions and symptoms — nausea, vomiting and trouble breathing — lifeguards can help.
Jellyfish blooms, sudden fluctuations in jellyfish populations, are not uncommon, said Gisele Muller-Parker, a retired marine biologist who would count dozens of lion's mane jellyfish during her daily Lewes Beach walks in July. Temperature, salinity and food availability influence jellyfish breeding, and in favorable conditions, such as warmer waters, populations can explode.
'This year, we've never seen anything like this,' Muller-Parker said.
The jellyfish were near the end of their life cycle, finishing their reproductive phase and laying their eggs. Those jellyfish will die once water temperatures cool, said Keith Bayha, a research collaborator with the Smithsonian Institution National Museum of Natural History.
The jellyfish boom can harm ecosystems and marine industries, said Bayha, who has studied the animals for more than 20 years and helped identify a nettle species. Fish larvae primarily feed on plankton, but jellyfish can eat both the plankton and the fish. And with few natural predators, the jellyfish food chain is an ecological dead end, said Bayha.
Delaware's boom this summer is far from alone. Florida's Volusia County reported hundreds of stings around Memorial Day weekend. Gloucester, Massachusetts, reminded beachgoers to stay safe around jellyfish in mid-July. And in June, Maine's Ogunquit Fire Department warned beachgoers about the increase in jellyfish after stings were reported.
Jellyfish research is limited, but Muller-Parker hopes more work will be done to assess the ecological ramifications of jellyfish blooms and improve safety advisories.
For now, some unlucky beachgoers will have to rely on home remedies and, in the case of Massachusetts resident Kathy Malloy-Harder's third-grade nephew, a little bravery.
'When he got stung, he jumped up and started crying and said, 'I'm never coming back to the beach again ever,'' said Malloy-Harder, who had to try two stores to find vinegar for him. But she said that after talking about it 'and once the sting subsided, he was interested in coming back and enjoying the beach.'
___
Whittle reported from Portland, Maine.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Washington Post
19 minutes ago
- Washington Post
This dog used to sniff out cold cases for police. Now she's saving bees.
Equipped with her own tailored bee suit and a hood to cover her floppy ears, Maple — a former police dog — has an important retirement task: helping save thousands of honeybee hives. The canine has spent the past five months sniffing Michigan bee colonies for American foulbrood, a highly contagious bacteria that's fatal to the insects. Maple, an English springer spaniel, uses her extraordinary sense of smell as a 'high-speed screening tool' to prevent beekeepers from having to manually inspect every hive.
Washington Post
19 minutes ago
- Washington Post
How lithium went from 7Up to treatment for mental illness — and maybe Alzheimer's
A study this week in the journal Nature found that the loss of lithium, a naturally occurring element in the brain, could be an early sign of Alzheimer's and a powerful driver of the disease, which afflicts more than 7 million Americans. The study, led by Bruce A. Yankner, a professor of genetics and neurology at Harvard Medical School, found that lithium is important to the health of all the major types of brain cells in mice. Depletion of lithium in the brain also seems to be a factor in almost all of the major deterioration that occurs with Alzheimer's disease. While the latest study of lithium is novel in pointing toward a potential Alzheimer's treatment, the use of lithium to treat other conditions is not. Here's a look at what it has worked for and how its use is being researched in new ways. Lithium, soft and silvery, is nature's lightest metal, enabling it to store energy at high density and discharge electrons rapidly. 'This is the basis of the lithium battery that powers our phones, laptops and electric vehicles,' Yankner said. Less well known is that the original formulation of the soft drink 7Up contained lithium; the drink was marketed under the name Bib-Label Lithiated Lemon-Lime Soda. The lithium was removed in 1948 after the Food and Drug Administration banned the use of lithium citrate in soft drinks. As of 2024, Australia was the world's largest producer of lithium, though Bolivia, Chile and Argentina are known as the 'lithium triangle.' A form of lithium, lithium carbonate, has been widely prescribed in the treatment of bipolar disease in the United States since it was first approved by the FDA in 1970. It is believed to be a mood stabilizer and can also be prescribed for long-term treatment of depression. While the precise mechanism of lithium carbonate isn't known, it is believed to suppress stress in the brain and help restore neuroplasticity — the brain's ability to change and adapt as we get older. One of the findings of the Nature study was that our brains contain a small amount of naturally occurring lithium. There are cases of lithium being used in psychiatry going back to the mid-19th century, but the study of lithium for mood disorders took a larger step in the late 1940s when an Australian psychiatrist, John Cade, found that it helped many bipolar patients stabilize quickly. 'It's been around for decades, and we have a lot of research and a lot of evidence supporting its use,' said Elizabeth Hoge, a professor of psychiatry at Georgetown University School of Medicine. 'The most important thing is that it does help patients. We know that it works from randomized, controlled trials.' Hoge said the use of lithium does require monitoring of renal and thyroid function, which can decline in some cases. Balwinder Singh, an assistant professor of psychiatry at the Mayo Clinic, said lithium remains the 'gold standard' medication for bipolar disorder, though it is under-prescribed in his view. About 10 to 15 percent of Americans with bipolar disorder take lithium, compared with about 35 percent of patients in Europe. 'Lithium is the only mood stabilizer consistently shown to reduce suicidality in individuals with bipolar disorder,' according to a recent comment Singh wrote in the journal Lancet Psychiatry. Although lithium has been widely prescribed and its use is supported in many studies, a 2022 paper argued that its effect on bipolar depression, a part of bipolar disorder, does not represent a statistically significant improvement over a placebo or antidepressants. Lithium had been investigated previously as a potential Alzheimer's treatment and antiaging medication. A 2017 study in Denmark found that the presence of lithium in drinking water might be linked to a lower incidence of dementia in the population. Yankner's lab became interested in lithium after measuring the levels of 30 different metals in the brain and blood of people who were cognitively healthy, people in a very early stage of dementia and people with full-blown Alzheimer's disease. Of the 30 metals, only lithium changed significantly among the three groups. Lithium maintains the connections and communication lines that allow neurons in a healthy brain to talk with one another. The metal also helps form the myelin that coats and insulates the communication lines and helps microglial cells clear cellular debris that can impede brain function. All this adds up to promoting good memory function both in mice and in humans, researchers said. Yankner's lab found that small amounts of the compound lithium orotate were able to reverse a mouse model of Alzheimer's disease and restore brain function. Researchers said the discovery should be enough to spur clinical trials for testing the compound in people. But Yankner said he could not recommend at this point that people start taking lithium because its use for Alzheimer's has not been validated in people, and 'things can change as you go from mice to humans.' Lithium can also be toxic if not regulated properly. And because this research is nascent, it's unlikely that a treatment will be available anytime soon.
Yahoo
26 minutes ago
- Yahoo
Masimo appoints several senior execs, resolves cyber incident
This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. By the numbers Q2 revenue: $370.9 million 7.9% increase year over year Net income from continuing operations: $44.9 million 81% increase year over year Masimo said it has implemented measures that reduced its tariff burden by more than half and resolved a cybersecurity incident that occurred in the spring. The patient monitoring company said second-quarter revenue met expectations, and adjusted earnings per share grew 46% year over year due to continuing cost structure actions under new CEO Katie Szyman. The executive joined Masimo in February from BD, taking the job months after founder Joe Kiani left the company following a protracted proxy battle. On a Tuesday earnings call, Szyman unveiled several senior leadership hires, including Greg Meehan in the role of chief commercial officer. Also named were Huimin Wang as president of Japan and Asia Pacific, Tim Benner as chief marketing and strategy officer, Linnette Torres as executive vice president of quality and regulatory, and Giri Chodavarapu as chief information officer. In addition, Omar Ahmed was promoted to chief technology and innovation officer. Still, analysts raised concerns about the lack of a contract renewal with longtime customer Philips, weighing on Masimo's shares. The status of Masimo's relationship with Philips was a topic on the call, with one analyst pointing to a competitor's renewed partnership with the equipment manufacturer. Medtronic announced last month that it signed a multiyear agreement with Philips in patient monitoring. Szyman said Masimo's agreement with Philips is still in place, and the companies are in talks to continue the partnership 'well into the future.' The relationship with Philips remains 'very strong,' she said. Masimo, which boosted its full-year earnings forecast, said the update includes a $17 million to $19 million increase to its cost of sales from tariffs and 25-cent impact on earnings per share, down from the range of 45 cents to 50 cents forecast in May. Including the impact of tariffs, adjusted earnings are now projected in a range of $5.20 to $5.45 per share, up from the previous $4.80 to $5.15. Cyberattack and Sound United sale CFO Micah Young said Masimo incurred net expenses of about $4.5 million to recover and fortify its systems with the help of a team of outside experts, following a spring cybersecurity incident. Masimo discovered unauthorized activity on its on-premises network on April 27. The attack on some of its manufacturing facilities disrupted the company's website and several computer systems. When it disclosed the incident in May, the company warned the attack had affected its ability to fulfill orders. The divestiture of Sound United, announced in May, remains on track to close by the end of the year, Young said. Masimo plans to sell the consumer audio business for $350 million to Samsung Electronics' Harman International unit, to focus on its professional healthcare business. Recommended Reading Masimo says cyberattack has impacted its ability to fulfill orders Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
